Compare SGA & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGA | ELOX |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 52.5M |
| IPO Year | 1994 | 2013 |
| Metric | SGA | ELOX |
|---|---|---|
| Price | $5.92 | $10.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 16.1K | ★ 19.4K |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | ★ 15.15% | N/A |
| EPS Growth | N/A | ★ 41.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $124,829,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.65 | N/A |
| 52 Week Low | $6.55 | $10.00 |
| 52 Week High | $12.76 | $23.40 |
| Indicator | SGA | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 19.91 | 35.60 |
| Support Level | N/A | N/A |
| Resistance Level | $9.41 | $14.65 |
| Average True Range (ATR) | 0.44 | 1.08 |
| MACD | -0.11 | -0.18 |
| Stochastic Oscillator | 25.87 | 25.38 |
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.